Creatine Safety & Tolerability in Huntington's Disease

NCT01412151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Huntington's Disease (HD)

Interventions

DRUG: Creatine monohydrate

Sponsor

Massachusetts General Hospital